Tesla Musk Spacex
Tesla, SpaceX, and the Weight of Elon Musk's Words
Four words from Elon Musk on Tesla's Q2 earnings call — 'more and more overlap' between Tesla and SpaceX — prompted Gene Munster of Deepwater Asset Management to raise his probability estimate for a merger between the two companies to 90 percent. That figure represents one analyst's model built on a phrase from a single earnings call, not a market consensus, and Munster has been a long-standing Tesla bull. The substantive question his thesis raises is what the 'overlap' actually describes: energy systems, autonomous hardware, and manufacturing processes are the most plausible candidates.
Short sellers have doubled their profits on SpaceX to $15.5 billion as the company's stock has sunk below its IPO price — a significant reversal for a company that commanded extraordinary private market valuations, reflecting both the general repricing of growth assets in a higher-rate environment and concerns about the Optimus humanoid robot production timeline.
Musk acknowledged on the earnings call that Optimus production will be 'extremely challenging' — an unusual public concession — while simultaneously dismissing competitor humanoid robot demonstrations as 'pre-scripted.' The combination of criticizing competitors while acknowledging internal difficulties suggests the humanoid robotics space is proving harder than any of its participants publicly admitted.
The National Highway Traffic Safety Administration has begun rulemaking on Tesla door egress systems, developing new safety requirements in response to incidents where occupants became trapped after crashes. The rulemaking process is expected to take eighteen months to two years to produce final regulations, but it signals that federal regulators are treating Tesla's door design as a systemic safety pattern rather than isolated incidents. Separately, in an interview with The Economist, Musk said he 'got carried away' with politics — while asserting that 'zero people died' from DOGE's federal funding cuts, a claim researchers have directly disputed.